Skip to content

Mathilde Argote

3 papers in the library · 38 citations · publishing 2022-2026

Papers

Sort Most recent Most cited

Impact of cannabis use and cannabis composition on formal thought disorder and related brain networks: An fMRI study in 51 patients with schizophrenia

Schizophrenia Research October 23, 2026 Thomas Bernabeu, Mathilde Argote, Antony Citterio‐Quentin et al.

BACKGROUND: Formal thought disorder (FTD) is a core dimension of schizophrenia, which has been associated in previous studies with increased brain functional connectivity between temporal gyri and striatal regions as measured with fMRI. Cannabis use is highly prevalent in schizophrenia population as compared with the general population and, in the context of elevated...

Association between cannabis use and symptom dimensions in schizophrenia spectrum disorders: an individual participant data meta-analysis on 3053 individuals

EClinicalMedicine September 8, 2023 Mathilde Argote, Guillaume Sescousse, Jérôme Brunelin et al. 31 citations

Background: The association between cannabis use and positive symptoms in schizophrenia spectrum disorders is well documented, especially via meta-analyses. Yet, findings are inconsistent regarding negative symptoms, while other dimensions such as disorganization, depression, and excitement, have not been investigated. In addition, meta-analyses use aggregated data discarding important...

Association between formal thought disorder and cannabis use: a systematic review and meta-analysis

Schizophrenia September 29, 2022 Mathilde Argote, Guillaume Sescousse, Jérôme Brunelin et al. 7 citations

Formal thought disorder (FTD) is a multidimensional syndrome mainly occurring along the psychosis continuum. Cannabis use is known to increase symptoms of psychosis, particularly positive symptoms. However, the impact of cannabis use on FTD in individuals presenting symptoms along the psychosis continuum remains unclear. To address this knowledge gap, we conducted a meta-analysis examining the...